FIELD: chemistry and pharmaceuticals.
SUBSTANCE: invention relates to the field of chemistry and pharmaceuticals, namely to a means for the prevention and treatment of metabolic syndrome, characterized in that it contains a mixture of polyprenyl phosphates absorbed in lecithin using microcrystalline cellulose as a solid base with a number of isoprene units from 7 to 30 or their physiologically acceptable salts.
EFFECT: technical result consists in normalizing the intestinal flora, reducing insulin levels, increasing insulin sensitivity, increasing adiponectin levels, reducing leptin levels, lowering cholesterol, low-density lipoproteins and triglycerides.
4 cl, 7 dwg, 5 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING METABOLIC SYNDROME | 2014 |
|
RU2580757C1 |
| METHOD OF TREATING PATIENTS WITH METABOLIC SYNDROME | 2018 |
|
RU2699508C1 |
| MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
| METHOD OF TREATING OBESITY | 2013 |
|
RU2511068C1 |
| COMPOSITION FOR CORRECTION OF DYSLIPIDEMIA AND MAINTENANCE OF FUNCTIONAL STATE OF HUMAN BODY IN METABOLIC SYNDROME | 2018 |
|
RU2681853C1 |
| DRUG SUBSTANCE OF POLYPRENYLPHOSPHATES AND BETA-SITOSTEROL AND METHOD FOR PREPARING IT | 2014 |
|
RU2542420C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
| USE OF COMPOSITIONS CONTAINING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-28149 | 2015 |
|
RU2673341C2 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
| METHOD FOR CORRECTING METABOLIC DISORDERS IN PERIMENOPAUSAL WOMEN | 2021 |
|
RU2767879C1 |
